Miguel Peixoto
Family · Chelmsford, MANPI 1083670764
Payments from drug & device makers
Across 236 payments — averaging $19.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$757
- Novo Nordisk$466
- Pfizer$412
- AstraZeneca$406
- GSK$363
- Astellas Pharma US Inc$255
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,40397%
- Education$1193%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $757 |
| Novo Nordisk | 26 | $466 |
| Pfizer | 19 | $412 |
| AstraZeneca | 23 | $406 |
| GSK | 20 | $363 |
| Astellas Pharma US Inc | 8 | $255 |
| Boehringer Ingelheim | 11 | $216 |
| Abbott | 7 | $139 |
| Janssen Scientific Affairs, LLC | 4 | $139 |
| Johnson & Johnson | 6 | $130 |
| Bayer | 6 | $120 |
| Lilly USA, LLC | 6 | $113 |
| Exact Sciences | 5 | $113 |
| Lundbeck LLC | 6 | $110 |
| Vanda Pharmaceuticals Inc. | 2 | $73 |
| Amgen | 4 | $72 |
| Mylan Specialty L.p. | 4 | $62 |
| Baxter Healthcare | 1 | $61 |
| Sumitomo Pharma America, Inc. | 4 | $61 |
| Alnylam Pharmaceuticals Inc. | 3 | $55 |
| Merck | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Inspire Medical Systems, Inc. | 2 | $40 |
| Amarin Pharma, Inc. | 3 | $39 |
| Novartis | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Pulmonx Corporation | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Echosens North America, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Genentech USA, Inc. | 2 | $13 |
| Esperion Therapeutics, Inc. | 1 | $12 |
How this compares
$4,521 in reported general payments places this provider in the 95th percentile of 2,320 family providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $18,754 |
| Potassium Chloride | 13 | $2,168 |
| Metoprolol Succinate | 43 | $1,330 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $1,185 |
| Omeprazole | 69 | $1,105 |
| Atorvastatin Calcium | 80 | $1,030 |
| Rosuvastatin Calcium | 28 | $930 |
| Famotidine | 60 | $921 |
| Losartan Potassium | 48 | $854 |
| Metformin Hcl ErMetformin Hcl | 48 | $808 |
| Pravastatin Sodium | 34 | $776 |
| Amlodipine Besylate | 98 | $719 |
| Lisinopril | 65 | $716 |
| Tamsulosin Hcl | 29 | $712 |
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 20 | $636 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $412 | $18,75413 claims |
| AbbVieArmour Thyroid | $757 | $37812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,320 family providers in Massachusetts.
Other family in Chelmsford
- Jennifer AndersonChelmsford$14K
- Paul GouldLakeville$343K
- Brittany MurrayBoston$141K
- Courtney NixonAmherst$81K
- Elizabeth WalshBrighton$80K
- Jennifer FlemingLawrence$80K
- Naomi AmudalaBoston$79K
- Geoffrey WhitleyCharlestown$66K
- Katherine O'BrienWinthrop$58K
- Kristy SmithActon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.